Abstract
The diagnosis of Noonan syndrome is essentially clinical, based upon the distinct phenotype and the involvement of the cardiovascular system. Tumor development is a rare manifestation of Noonan syndrome but can be explained by the molecular pathophysiology involved in the disorder. We present three Noonan patients who developed solid tumors. The first patient, a 4-year-old girl, developed granular cell tumors as did her mother in childhood. The second patient, a 1-year-old boy, had a low grade pilocytic astrocytoma, the clinical expression of which was persistent headache. MRI showed a pituitary mass in the posterior lobe. It was surgically removed. The third patient, a 7-year-old boy was found to have Sertoli tumors in his right cryptorchid testis. All three patients fulfilled the clinical criteria for Noonan syndrome. However, genetic testing was negative in patients 1 and 3. The diagnosis of Noonan syndrome was made based on distinct phenotypic findings in three patients who had different types of tumors.
Similar content being viewed by others
Abbreviations
- ECG:
-
Electrocardiograph
- EGF:
-
Epithelial growth factor
- EGFR:
-
Epithelial growth factor receptor
- FGF:
-
Fibroblast growth factor
- GFAP:
-
Glial fibrillary acidic protein
- HGF:
-
Hepatocyte growth factor
- IL-1:
-
Interleukin 1
- KRAS:
-
Kirsten rat sarcoma viral oncogene homologue
- MRI:
-
Magnetic resonance imaging
- NFP:
-
Neurofilament protein
- NS:
-
Noonan syndrome
- NSE:
-
Neuron-specific enolase
- PTPN11:
-
Protein tyrosine phosphatase, nonreceptor type 11
- RAF:
-
Murine sarcoma viral oncogene homologue
- RAS:
-
Rat sarcoma viral oncogene homologue
- SIADH:
-
Syndrome of inappropriate antidiuretic hormone
- SOS1:
-
Son of sevenless drosophila, homologue 1
- TNF:
-
Tumor necrosis factor
- WHO:
-
World Health Organisation
References
Aggrawal A, Krishnan J, Kwart A, Perry D (2001) Noonan’s syndrome and seminoma of undescended testicle. South Med J 94:432–434
Allanson JE (1987) Noonan syndrome. J Med Genet 24:9–13
Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG (2004) Activating mutations of the Noonan syndrome-associated SHP-2/PTPN11 gene in human solid tumours and in acute myelogenous leukemia. Cancer Res 64:8816–8820
Bertola DR, Kim CA, Sugayama SMM, Albano LM, Wagenfuhr J, Moyses RL, Gonzalez CH (2000) Cardiac findings in 31 patients with Noonan syndrome. Arq Bras Cardiol 75:409–412
Chen Y, Takita J, Hiwatari M, Igarashi T, Hanada R, Kikuchi A, Hongo T, Taki T, Ogasawara M, Shimada A, Hayashi Y (2006) Mutations of PTPN11 and RAS genes in rhabdomyosarcoma and pediatric haematological malignancies. Genes Chromosomes Cancer 45:583–591
Cotton JL, Williams RG (1995) Noonan syndrome and neuroblastoma. Arch Pediatr Adolesc Med 149:1280–1281
Deck JH, Eng LF, Bigdee J, Woodcock SM (1978) The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors. Acta Neuropathol 42:183–190
Fisher ER, Wechsler H (1962) Granular cell myoblastoma—a misnomer. Cancer 21:936–954
Garner MJ, Turner MC, Gharidion P, Krewski D (2005) Epidemiology of testicular cancer: an overview. Int J Cancer 116:331–339
Hilbig A, Barbosa-Coutinho LM, Netto GC, Bleil CB, Toscani NV (2006) Immunochemistry in oligodendrogliomas. Arq Neuropsiquitr 64:67–71
Jameson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, Jeffey S, Patton MA, Mariman E (1994) Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 8:357–360
Johannessen AL, Torp SH (2006) The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas. Pathol Oncol Res 12:143–147
Jongmans M, Sistermans EA, Rikken A, Nillesen WM, Tamminga R, Patton M, Maier EM, Tartaglia M, Noordam K, van der Burgt I (2005) Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature. Am J Med Genet 134A:165–170
Lohmann DR, Gillessen-Kaesbach G (2000) Multiple subcutaneous granular cell tumours in a patient with Noonan syndrome. Clin Dysmorphol 9:301–302
Martinelli S, Carte C, Flex E, Binni F, Cordisco EL, Moretti S, Puxeddu E, Tonacchera M, Pinchera A, McDowell HP, Dominici C, Rosolen A, Di Rocco C, Riccardi R, Celli P, Picardo M, Genuardi M, Grammatico P, Sorcini M, Tartaglia M (2006) Activating PTPN11 mutations play a minor role in pediatric and adult solid tumours. Cancer Genet Cytogenet 166:124–129
Moschovi M, Touliatou V, Papadopoulou A, Mayakou MA, Nikolaidou P, Kitsiou-Tzeli S (2007) Rhabdomyosarcoma in a patient with Noonan syndrome phenotype and review of the literature. J Pediatr Hematol Oncol 29:341–344
Musante L, Kehl HG, Majewski P, Meinecke P, Schweiger S, Gillessen-Kaesbach G, Wieczork D, Hinkel GK, Tinschert S, Hoeltzenbein M, Ropers HH, Kalscheuer VM (2003) Spectrum of mutations in PTPN11 and genotype–phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet 11:201–206
Noonan JA (1968) Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child 116:373–380
Nora JJ, Nora AH, Sinha AK, Spangler RD, Lubs HA (1974) The Ullrich–Noonan syndrome (Turner phenotype). Am J Dis Child 127:4-55
Omuro AM, Leite CC, Mokhitari K, Delattre JY (2006) Pitfalls in the diagnosis of brain tumors. Lancet Neurol 5:937–948
Opitz JM, Weaver DD (1985) The neurofibromatosis-Noonan syndrome. Am J Med Genet 21:477–490
Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, Pogna EA, Schackwitz W, Ustaszewska A, Landstrom A, Bos JM, Ommen SR, Esposito G, Lepri F, Faul C, Mundel P, López Siguero JP, Tenconi R, Selicorni A, Rossi C, Mazzanti L, Torrente I, Marino B, Digilio MC, Zampino G, Ackerman MJ, Dallapiccola B, Tartaglia M, Gelb BD (2007) Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39:1007–1012
Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, Kamisago M, Momma K, Katayama H, Nakagawa M, Fujiwara Y, Matsushima M, Mizuno K, Tokuyama M, Hirota H, Muneuchi J, Higashinakagawa T, Matsuoka R (2007) Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 39:1013–1017
Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS (2007) Germline gain of function mutations in SOS1 cause Noonan syndrome. Nat Genet 39:70–74
Ross JH, Rubicki L, Kay R (2002) Clinical behavior and a contemporary management algorithm for prepubetal testis tumors: a summary of the Prepuertal Testis Tumor Registry. J Urol 168:1675–1679
Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, Tandoi C, Fazio VM, Di Commo V, Marino B, Pizzuti A, Dallapiccola B (2003) Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and Leopard syndromes. J Med Genet 40:704–708
Schollen E, Matthijs G, Gewillig M, Fryns JP, Legius E (2003) PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning. Eur J Hum Genet 11:85–88
Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, van der Bugt I, Musante l, Kalschuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemyer CM, Shannon K, Kratz CP (2006) Germline KRAS mutations cause Noonan syndrome. Nat Genet 38:331–336
Smirniotopoulos JH (1999) The new WHO classification of brain tumors. Neuroimaging Clin N Am 9:595–613
Stavrianeas N, Cakepis E, Nicolis G, Capetanakis J (1979) Association de multiples tumours d’Abrikossoff disséminées sur le corps et les members avec des anomalies oculo-cardiaques chez une fille de 8 ans. Ann Dermatol Venereol (Paris) 106:609–610
Sznajer Y, Keren B, Baumann C, Pereira S, Alberti C, Elion J, Cavé H, Verloes A (2007) The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene. Pediatrics 119:1325–1331
Tanaka Y, Masuno M, Iwamoto H, Aida N, Ijiri R, Yamanaka S, Imaizumi K, Kuroki Y (1999) Noonan syndrome and cavernous hemangioma of the brain. Am J Med Genet 82:212–214
Tartaglia M, Gelb BD (2005) Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet 48:81–96
Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD (2002) PTPN 11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation and phenotypic heterogeneity. Am J Hum Genet 70:1555–1563
Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Arico M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A (2004) Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations in leukemogenesis in childhood acute leukemia. Blood 104:307–313
Tartaglia M, Mehler E, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb B (2001) Mutations in PTPN11, encoding the protein phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465–468
Tartaglia M, Pennachio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, Ustaszewska A, Martin J, Bristow J, Carta C, Lepri F, Neri C, Vasta I, Gibson K, Curry CJ, Siguero JP, Digilio MC, Zampino G, Dallapiccola B, Bar-Sagi D, Gelb BD (2007) Gain-of-function SOS 1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39:75–79
van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E (1994) Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 53:187–191
Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, Tietze HU, Doerr HG, Hofbeck M, Singer H, Reis A, Rauch A (2004) Genotype–phenotype correlations in Noonan syndrome. J Pediatr 144:368–374
Zenker M, Horn D, Wieczorek D, Allanson J, Pauli S, van der Burgt I, Doerr HG, Gaspar H, Hofbeck M, Gillessen-Kaesbach G, Koch A, Meinecke P, Nowak A, Rauch A, Reif S, von Schnakenburg C, Seidel H, Wehner LE, Zweier C, Bauhuber S, Matejas V, Kratz CP, Thomas C, Kutsche K (2007) SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet 44:651–656
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fryssira, H., Leventopoulos, G., Psoni, S. et al. Tumor development in three patients with Noonan syndrome. Eur J Pediatr 167, 1025–1031 (2008). https://doi.org/10.1007/s00431-007-0636-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0636-3